Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>HENGRUI PHARMA IPO Said to Be Priced at Upper Limit of HKD44.05
Recommend 21 Positive 32 Negative 10 |
||||
|
||||
|
China's innovative pharmaceutical company, HENGRUI PHARMA (01276.HK) will raise $9.89 billion in its IPO at a cap offer price of $44.05, IFR quoted sources as saying. It was previously rumored that, due to strong demand for IPO subscription, HENGRUI PHARMA would close institutional investor subscriptions a day early at 5 PM on Monday (19th). It is reported that institutional investor demand has topped the entire offering size. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
